Tag: Mircera

Mircera, an erythropoiesis-stimulating agent (ESA), was first approved by the FDA in 2007. The generic name for Mircera is methoxy polyethylene glycol-epoetin beta, a modified version of the naturally occurring hormone erythropoietin used to treat anemia associated with chronic kidney disease (CKD).

Confusion in medicine can have serious consequences, and the term “mirra” does not correspond to a single, recognized drug name, instead representing a common misnomer for several distinct products. Understanding **what is the use of mirra** requires distinguishing it from various substances, such as the herbal remedy myrrh, the prescription drug Myrbetriq, and the laxative Miralax.